secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K/A
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001731122-24-001672
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro assigns committee roles to four directors effective Oct 23, 2024
-------------------------------------------------------------------------

- Maurice van Tilburg appointed to Nominating & Governance and Special Litigation committees.
- James A. McNulty named Audit Committee Chair, also on Compensation and Special Litigation.
- Douglas W. Calder joins Audit, Nominating & Governance, and Compensation committees.
- Mark A. Collins, PhD, appointed to Audit and Special Litigation committees.
- All directors will enter standard indemnification agreements with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001672/0001731122-24-001672-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001672/e6067_8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001672

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer